KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis

Cancer and Metastasis Reviews

Volumn 31, Issue 3-4, 2012, Pages 585-591

  Cho, Sung Gook ^a   Li, Dali ^b   Tan, Kunrong ^a   Siwko, Stefan K ^a   Liu, Mingyao ^a,b  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Cancer; GPR54; KiSS1; Kisspeptin; Metastasis

Indexed keywords

ANTIMETASTATIC AGENT; ANTINEOPLASTIC AGENT; G PROTEIN COUPLED RECEPTOR 54; KISS1 PROTEIN; KISSPEPTIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; LOSS OF FUNCTION MUTATION; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL TIME;

ANIMALS; HUMANS; KISSPEPTINS; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84868002638     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-012-9367-7     Document Type: Article

References (61)

1. Smith, S. C.; & Theodorescu, D. (2009). Learning therapeutic 9lessons from metastasis suppressor proteins. Nature Reviews Cancer, 9(4), 253-264. doi: 10.1038/nrc2594.
2. Hanahan, D.; & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. [Research Support, N.I.H.; Extramural Review]. Cell, 144(5), 646-674. doi: 10.1016/j.cell.2011.02.013.
3. Fullgrabe, J.; Kavanagh, E.; & Joseph, B. (2011). Histone onco-modifications. Oncogene, 30(31), 3391-3403. doi: 10.1038/onc.2011.121.
4. Sharma, S.; Kelly, T. K.; & Jones, P. A. (2010). Epigenetics in cancer. Carcinogenesis, 31(1), 27-36. doi: 10.1093/carcin/bgp220.
5. De Bock, K.; Mazzone, M.; & Carmeliet, P. (2011). Antiangiogenic therapy, hypoxia, and metastasis: Risky liaisons, or not? [Research Support, Non-U.S. Gov't Review]. Nature Reviews. Clinical Oncology, 8(7), 393-404. doi: 10.1038/nrclinonc.2011.83.
6. Thiery, J. P.; Acloque, H.; Huang, R. Y.; & Nieto, M. A. (2009). Epithelial-mesenchymal transitions in development and disease. Cell, 139(5), 871-890. doi: 10.1016/j.cell.2009.11.007.
7. Shoushtari, A. N.; Szmulewitz, R. Z.; & Rinker-Schaeffer, C. W. (2011). Metastasis-suppressor genes in clinical practice: Lost in translation? Nature Reviews Clinical Oncology, 8(6), 333-342. doi: 10.1038/nrclinonc.2011.65.
8. Cook, L. M.; Hurst, D. R.; & Welch, D. R. (2011). Metastasis suppressors and the tumor microenvironment. Seminars in Cancer Biology, 21(2), 113-122. doi: 10.1016/j.semcancer.2010.12.005.
9. Lee, J. H.; & Welch, D. R. (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Research, 57(12), 2384-2387.
10. Nash, K. T.; & Welch, D. R. (2006). The KISS1 metastasis suppressor: Mechanistic insights and clinical utility. Frontiers in Bioscience, 11, 647-659.
11. Lee, J. H.; Miele, M. E.; Hicks, D. J.; Phillips, K. K.; Trent, J. M.; Weissman, B. E.; et al. (1996). KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. Journal of the National Cancer Institute, 88(23), 1731-1737.
12. Seminara, S. B.; & Kaiser, U. B. (2005). New gatekeepers of reproduction: GPR54 and its cognate ligand, KiSS-1. Endocrinology, 146(4), 1686-1688. doi: 10.1210/en.2005-0070.
13. Ohtaki, T.; Shintani, Y.; Honda, S.; Matsumoto, H.; Hori, A.; Kanehashi, K.; et al. (2001). Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature, 411(6837), 613-617. doi: 10.1038/35079135.
14. Mitchell, D. C.; Abdelrahim, M.; Weng, J.; Stafford, L. J.; Safe, S.; Bar-Eli, M.; et al. (2006). Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1. Journal of Biological Chemistry, 281(1), 51-58. doi: 10.1074/jbc.M506245200.
15. Mitchell, D. C.; Stafford, L. J.; Li, D.; Bar-Eli, M.; & Liu, M. (2007). Transcriptional regulation of KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactivator DRIP-130. Oncogene, 26(12), 1739-1747. doi: 10.1038/sj.onc.1209963.
16. Nash, K. T.; Phadke, P. A.; Navenot, J. M.; Hurst, D. R.; Accavitti-Loper, M. A.; Sztul, E.; et al. (2007). Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. Journal of the National Cancer Institute, 99(4), 309-321. doi: 10.1093/jnci/djk053.
17. Seminara, S. B.; Messager, S.; Chatzidaki, E. E.; Thresher, R. R.; Acierno, J. S.; Jr.; Shagoury, J. K.; et al. (2003). The GPR54 gene as a regulator of puberty. The New England Journal of Medicine, 349(17), 1614-1627. doi: 10.1056/NEJMoa035322.
18. Teles, M. G.; Bianco, S. D.; Brito, V. N.; Trarbach, E. B.; Kuohung, W.; Xu, S.; et al. (2008). A GPR54-activating mutation in a patient with central precocious puberty. The New England Journal of Medicine, 358(7), 709-715. doi: 10.1056/NEJMoa073443.
19. Topaloglu, A. K.; Tello, J. A.; Kotan, L. D.; Ozbek, M. N.; Yilmaz, M. B.; Erdogan, S.; et al. (2012). Inactivating KISS1 mutation and hypogonadotropic hypogonadism. The New England Journal of Medicine, 366(7), 629-635. doi: 10.1056/NEJMoa1111184.
20. Silveira, L. G.; Noel, S. D.; Silveira-Neto, A. P.; Abreu, A. P.; Brito, V. N.; Santos, M. G.; et al. (2010). Mutations of the KISS1 gene in disorders of puberty. Journal of Clinical Endocrinology and Metabolism, 95(5), 2276-2280. doi: 10.1210/jc.2009-2421.
21. Lapatto, R.; Pallais, J. C.; Zhang, D.; Chan, Y. M.; Mahan, A.; Cerrato, F.; et al. (2007). Kiss1-/- mice exhibit more variable hypogonadism than Gpr54-/- mice. Endocrinology, 148(10), 4927-4936. doi: 10.1210/en.2007-0078.
22. Morelli, A.; Marini, M.; Mancina, R.; Luconi, M.; Vignozzi, L.; Fibbi, B.; et al. (2008). Sex steroids and leptin regulate the first Kiss (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone- secreting neuroblasts. The Journal of Sexual Medicine, 5(5), 1097-1113. doi: 10.1111/j.1743-6109.2008.00782.x.
23. Horikoshi, Y.; Matsumoto, H.; Takatsu, Y.; Ohtaki, T.; Kitada, C.; Usuki, S.; et al. (2003). Dramatic elevation of plasma metastin concentrations in human pregnancy: Metastin as a novel placenta-derived hormone in humans. Journal of Clinical Endocrinology and Metabolism, 88(2), 914-919.
24. Janneau, J. L.; Maldonado-Estrada, J.; Tachdjian, G.; Miran, I.; Motte, N.; Saulnier, P.; et al. (2002). Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. Journal of Clinical Endocrinology and Metabolism, 87(11), 5336-5339.
25. Mead, E. J.; Maguire, J. J.; Kuc, R. E.; & Davenport, A. P. (2007). Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology, 148(1), 140-147. doi: 10.1210/en.2006-0818.
26. Ramaesh, T.; Logie, J. J.; Roseweir, A. K.; Millar, R. P.; Walker, B. R.; Hadoke, P. W.; et al. (2010). Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro. Endocrinology, 151(12), 5927-5934. doi: 10.1210/en.2010-0565.
27. Cho, S. G.; Yi, Z.; Pang, X.; Yi, T.; Wang, Y.; Luo, J.; et al. (2009). Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Research, 69(17), 7062-7070. doi: 10.1158/0008-5472.CAN-09-0476.
28. Muir, A. I.; Chamberlain, L.; Elshourbagy, N. A.; Michalovich, D.; Moore, D. J.; Calamari, A.; et al. (2001). AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. Journal of Biological Chemistry, 276(31), 28969-28975. doi: 10.1074/jbc.M102743200.
29. Kotani, M.; Detheux, M.; Vandenbogaerde, A.; Communi, D.; Vanderwinden, J. M.; Le Poul, E.; et al. (2001). The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. Journal of Biological Chemistry, 276(37), 34631-34636. doi: 10.1074/jbc.M104847200.
30. Cho, S. G.; Li, D.; Stafford, L. J.; Luo, J.; Rodriguez-Villanueva, M.; Wang, Y.; et al. (2009). KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. Journal of Cellular Biochemistry, 107(6), 1139-1149. doi: 10.1002/jcb.22216.
31. Masui, T.; Doi, R.; Mori, T.; Toyoda, E.; Koizumi, M.; Kami, K.; et al. (2004). Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochemical and Biophysical Research Communications, 315(1), 85-92. doi: 10.1016/j.bbrc.2004.01.021.
32. Becker, J. A.; Mirjolet, J. F.; Bernard, J.; Burgeon, E.; Simons, M. J.; Vassart, G.; et al. (2005). Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochemical and Biophysical Research Communications, 326(3), 677-686. doi: 10.1016/j.bbrc.2004.11.094.
33. Navenot, J. M.; Fujii, N.; & Peiper, S. C. (2009). Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Molecular Pharmacology, 75(6), 1300-1306. doi: 10.1124/mol.109.055095.
34. Zhao, X.; Lu, L.; Pokhriyal, N.; Ma, H.; Duan, L.; Lin, S.; et al. (2009). Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Research, 69(2), 483-491. doi: 10.1158/0008-5472.CAN-08-2907.
35. Chang, Y. W.; Marlin, J. W.; Chance, T. W.; & Jakobi, R. (2006). RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility. Cancer Research, 66(24), 11700-11708. doi: 10.1158/0008-5472.CAN-06-1818.
36. Navenot, J. M.; Fujii, N.; & Peiper, S. C. (2009). KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis. Molecular Pharmacology, 75(5), 1074-1083. doi: 10.1124/mol.108.054270.
37. Stathatos, N.; Bourdeau, I.; Espinosa, A. V.; Saji, M.; Vasko, V. V.; Burman, K. D.; et al. (2005). KiSS-1/G protein-coupled receptor 54 metastasis suppressor pathway increases myocyte-enriched calcineurin interacting protein 1 expression and chronically inhibits calcineurin activity. Journal of Clinical Endocrinology and Metabolism, 90(9), 5432-5440. doi: 10.1210/jc.2005-0963.
38. Martins, C. M.; Fernandes, B. F.; Antecka, E.; Di Cesare, S.; Mansure, J. J.; Marshall, J. C.; et al. (2008). Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye (London, England), 22(5), 707-711. doi: 10.1038/sj.eye.6703090.
39. Dissanayake, S. K.; Wade, M.; Johnson, C. E.; O'Connell, M. P.; Leotlela, P. D.; French, A. D.; et al. (2007). The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. Journal of Biological Chemistry, 282(23), 17259-17271. doi: 10.1074/jbc.M700075200.
40. Dittmer, A.; Schunke, D.; & Dittmer, J. (2008). PTHrP promotes homotypic aggregation of breast cancer cells in three-dimensional cultures. Cancer Letters, 260(1-2), 56-61. doi: 10.1016/j.canlet.2007.10.020.
41. Stark, A. M.; Tongers, K.; Maass, N.; Mehdorn, H. M.; & Held-Feindt, J. (2005). Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. Journal of Cancer Research and Clinical Oncology, 131(3), 191-198. doi: 10.1007/s00432-004-0629-9.
42. Kostadima, L.; Pentheroudakis, G.; & Pavlidis, N. (2007). The missing kiss of life: Transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer. Anticancer Research, 27(4B), 2499-2504.
43. Martin, T. A.; Watkins, G.; & Jiang, W. G. (2005). KiSS-1 expression in human breast cancer. Clinical & Experimental Metastasis, 22(6), 503-511. doi: 10.1007/s10585-005-4180-0.
44. Marot, D.; Bieche, I.; Aumas, C.; Esselin, S.; Bouquet, C.; Vacher, S.; et al. (2007). High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocrine-Related Cancer, 14(3), 691-702. doi: 10.1677/ERC-07-0012.
45. Cho, S. G.; Wang, Y.; Rodriguez, M.; Tan, K.; Zhang, W.; Luo, J.; et al.(2011) Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Research, 71(20), 6535-6546, doi: 10.1158/0008-5472.CAN-11-0329.
46. Jiang, Y.; Berk, M.; Singh, L. S.; Tan, H.; Yin, L.; Powell, C. T.; et al. (2005). KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clinical & Experimental Metastasis, 22(5), 369-376. doi: 10.1007/s10585-005-8186-4.
47. Hata, K.; Dhar, D. K.; Watanabe, Y.; Nakai, H.; & Hoshiai, H. (2007). Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. European Journal of Cancer, 43(9), 1452-1459. doi: 10.1016/j.ejca.2007.03.004.
48. Prentice, L. M.; Klausen, C.; Kalloger, S.; Kobel, M.; McKinney, S.; Santos, J. L.; et al. (2007). Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Medicine, 5, 33. doi: 10.1186/1741-7015-5-33.
49. Katagiri, F.; Nagai, K.; Kida, A.; Tomita, K.; Oishi, S.; Takeyama, M.; et al. (2009). Clinical significance of plasma metastin level in pancreatic cancer patients. Oncology Reports, 21(3), 815-819.
50. Nagai, K.; Doi, R.; Katagiri, F.; Ito, T.; Kida, A.; Koizumi, M.; et al. (2009). Prognostic value of metastin expression in human pancreatic cancer. Journal of Experimental & Clinical Cancer Research, 28, 9. doi: 10.1186/1756-9966-28-9.
51. Dhar, D. K.; Naora, H.; Kubota, H.; Maruyama, R.; Yoshimura, H.; Tonomoto, Y.; et al. (2004). Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. International Journal of Cancer, 111(6), 868-872. doi: 10.1002/ijc.20357.
52. Yamashita, S.; Tsujino, Y.; Moriguchi, K.; Tatematsu, M.; & Ushijima, T. (2006). Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Science, 97(1), 64-71. doi: 10.1111/j.1349-7006.2006.00136.x.
53. Lee, K. H.; & Kim, J. R. (2009). Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer. Oncology Research, 18(2-3), 107-116.
54. Yan, C.; Wang, H.; & Boyd, D. D. (2001). KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. Journal of Biological Chemistry, 276(2), 1164-1172. doi: 10.1074/jbc.M008681200.
55. Sanchez-Carbayo, M.; Belbin, T. J.; Scotlandi, K.; Prystowsky, M.; Baldini, N.; Childs, G.; et al. (2003). Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: Regulation of cell adhesion, apoptosis, and tumor suppression-related genes. Laboratory Investigation, 83(4), 507-517.
56. Ikeguchi, M.; Fukuda, K.; Yamaguchi, K.; Kondo, A.; Tsujitani, S.; & Kaibara, N. (2003). Quantitative analysis of heparanase gene expression in esophageal squamous cell carcinoma. Annals of Surgical Oncology, 10(3), 297-304.
57. Schmid, K.; Wang, X.; Haitel, A.; Sieghart, W.; Peck-Radosavljevic, M.; Bodingbauer, M.; et al. (2007). KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: An immunohistochemical study. Virchows Archiv, 450(2), 143-149. doi: 10.1007/s00428-006-0352-9.
58. Shengbing, Z.; Feng, L. J.; Bin, W.; Lingyun, G.; & Aimin, H. (2009). Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma. Anatomical Record (Hoboken), 292(8), 1128-1134. doi: 10.1002/ar.20950.
59. Sanchez-Carbayo, M.; Capodieci, P.; & Cordon-Cardo, C. (2003). Tumor suppressor role of KiSS-1 in bladder cancer: Loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. American Journal of Pathology, 162(2), 609-617. doi: 10.1016/S0002-9440(10)63854-0.
60. Nicolle, G.; Comperat, E.; Nicolaiew, N.; Cancel-Tassin, G.; & Cussenot, O. (2007). Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder. Annals of Oncology, 18(3), 605-607. doi: 10.1093/annonc/mdl421.
61. Simanovsky, M.; Berlinsky, S.; Sinai, P.; Leiba, M.; Nagler, A.; & Galski, H. (2008). Phenotypic and gene expression diversity of malignant cells in human blast crisis chronic myeloid leukemia. Differentiation, 76(8), 908-922. doi: 10.1111/j.1432-0436.2008.00270.x.